Docherty KF et al (2025) Efficacy and safety of finerenone across the ejection fraction spectrum in heart failure with mildly reduced or preserved ejection fraction: a prespecified analysis of the FINEARTS-HF trial, (in eng)
Reviewers mention a steady rise in focus that nudges them toward a lunchtime walk or an extra gym set
Mistake 3: not adjusting diet to match the new reality Retatrutide dramatically reduces appetite, but it does not change what foods are available to you
Pfizer had failed in its previous attempts to create a viable GLP-1 contender
CrossRef The efficacy and safety of novel antidiabetic agents in polycystic ovary syndrome: a network meta-analysis Junjie Lin, Rongtao Yang, Jiacheng Zhuang, Wenbo Zhang, Qiang Tong, Jiahui Liu, Ye Kang, Yuan Yuan Journal of Ovarian Research.2026;[Epub] CrossRef Hypothalamus-liver talks: whispers in the language of metabolism Vitor Ferreira, Iara Fernndez-Gonzlez, Jane Jose Vattathara, Amanda Rodrguez-Daz, Paola Fernndez-Sanmartn, Carlos Diguez Reviews in Endocrine and Metabolic Disorders.2026